CIM Investment Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.4K | Buy |
25,550
+12,822
| +101% | +$19.8K | 0.01% | 251 |
|
|
2025
Q1 | $15K | Sell |
12,728
-303
| -2% | -$358 | ﹤0.01% | 238 |
|
|
2024
Q4 | $23.8K | Hold |
13,031
| – | – | 0.01% | 247 |
|
|
2024
Q3 | $22.2K | Hold |
13,031
| – | – | 0.01% | 253 |
|
|
2024
Q2 | $17.9K | Sell |
13,031
-3,106
| -19% | -$4.26K | 0.01% | 255 |
|
|
2024
Q1 | $60.5K | Hold |
16,137
| – | – | 0.02% | 279 |
|
|
2023
Q4 | $158K | Hold |
16,137
| – | – | 0.05% | 273 |
|
|
2023
Q3 | $135K | Hold |
16,137
| – | – | 0.05% | 265 |
|
|
2023
Q2 | $215K | Hold |
16,137
| – | – | 0.07% | 240 |
|
|
2023
Q1 | $187K | Buy |
16,137
+555
| +4% | +$6.43K | 0.07% | 246 |
|
|
2022
Q4 | $127K | Hold |
15,582
| – | – | 0.05% | 232 |
|
|
2022
Q3 | $90K | Hold |
15,582
| – | – | 0.04% | 213 |
|
|
2022
Q2 | $69K | Hold |
15,582
| – | – | 0.03% | 226 |
|
|
2022
Q1 | $142K | Buy |
+15,582
| New | +$142K | 0.05% | 243 |
|